Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Appendiceal Perforation and the Role of Total Bilirubin at Presentation: A Single Center Prospective Cross-sectional Study in Nepal

NCT06956638 is registered in ClinicalTrials.gov with Nepalese Army Institute of Health Sciences as lead sponsor.

NCT NCT06956638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Appendiceal Perforation and the Role of Total Bilirubin at Presentation: A Single Center Prospective Cross-sectional Study in Nepal
Lead sponsor
Nepalese Army Institute of Health Sciences
Phase
Observational
Overall status
Completed
Start date
July 16, 2022
Completion date
March 12, 2025
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute appendicitis, appendicitis perforated